YLR163W-A Antibody

Shipped with Ice Packs
In Stock

Description

Gene Identification: YLR163W-A

YLR163W-A is a non-essential gene in Saccharomyces cerevisiae (budding yeast) located on chromosome XII. It is classified as a "questionable ORF" with limited functional characterization. Key features include:

FeatureDetails
Genomic CoordinatesChromosome XII: 255,567–256,079 (S288C reference genome)
Protein Length170 amino acids
Molecular Weight~19.8 kDa
Isoelectric PointPredicted pI: 4.85
ConservationNo orthologs identified in other species

No experimentally determined protein abundance or functional data (e.g., phenotypes, interactions) are available for this locus .

Antibody-Related Insights

While the provided sources extensively discuss antibodies (e.g., structure, therapeutic applications, and research techniques ), none mention an antibody targeting YLR163W-A.

Key antibody-related findings from the search results include:

  • Structural Features: Antibodies are Y-shaped proteins with Fab (antigen-binding) and Fc (effector function) regions .

  • Therapeutic Applications: Monoclonal antibodies target biomarkers like TNF-α, IL-17, and HER2 for diseases such as cancer and autoimmune disorders .

  • Research Techniques: Antibodies are used in ELISA, Western blot, and flow cytometry for protein detection and quantification .

Potential Explanations for the Absence of Data

  • Gene Characterization: YLR163W-A is poorly characterized, with no known associated protein function or disease relevance in yeast or humans.

  • Antibody Development: Antibodies are typically developed against proteins with established biological roles. The lack of functional data for YLR163W-A makes it an unlikely target for antibody production.

  • Nomenclature Confusion: The term "YLR163W-A Antibody" may conflate the gene name (YLR163W-A) with unrelated antibody research (e.g., CA125/MUC16 antibodies or SARS-CoV-2 neutralizing antibodies ).

Recommendations for Further Research

To investigate YLR163W-A further:

  1. Functional Studies: Perform knock-out experiments to assess phenotypic effects in yeast.

  2. Protein Characterization: Use mass spectrometry or immunoprecipitation to identify interacting partners.

  3. Antibody Generation: Develop custom polyclonal/monoclonal antibodies if the protein is confirmed to have research or clinical relevance .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Components: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YLR163W-AUncharacterized protein YLR163W-A antibody
Target Names
YLR163W-A
Uniprot No.

Q&A

What is YLR163W-A and why is it significant for yeast research?

YLR163W-A is an uncharacterized protein from Saccharomyces cerevisiae (strain S288c/Baker's yeast), which serves as an important model organism in molecular and cellular biology research. The protein is encoded by the YLR163W-A gene locus in the yeast genome. While its function remains largely uncharacterized, studying this protein contributes to our understanding of yeast proteome and potentially reveals novel cellular mechanisms. Antibodies against this protein serve as valuable tools for detecting, quantifying, and characterizing its expression, localization, and interactions in various experimental contexts. The significance lies in expanding our knowledge of the yeast proteome, which serves as a foundation for understanding eukaryotic cell biology more broadly .

What experimental applications can YLR163W-A antibody be used for?

YLR163W-A antibodies can be applied in several experimental techniques:

  • Western Blot (WB): For detecting and quantifying YLR163W-A protein in cell or tissue lysates, allowing analysis of protein expression levels across different experimental conditions.

  • Enzyme-Linked Immunosorbent Assay (ELISA): For quantitative detection of YLR163W-A in solution.

  • Immunoprecipitation (IP): For isolating YLR163W-A and its binding partners to study protein-protein interactions.

  • Immunofluorescence (IF): For visualizing subcellular localization of YLR163W-A in fixed yeast cells.

  • Chromatin Immunoprecipitation (ChIP): If YLR163W-A has any DNA-binding capacity, ChIP can be used to identify its genomic binding sites .

When designing experiments, researchers should validate antibody specificity using appropriate controls, including wild-type versus knockout strains, when possible.

What are the recommended sample preparation protocols for YLR163W-A antibody experiments?

Sample preparation for YLR163W-A detection requires careful consideration of yeast cell lysis conditions:

  • Cell lysis buffer selection: Use buffers containing 50mM Tris-HCl (pH 7.5), 150mM NaCl, 1% Nonidet P-40, and protease inhibitor cocktail. For membrane-associated proteins, consider adding 0.5% sodium deoxycholate.

  • Mechanical disruption methods:

    • Glass bead lysis: Most effective for yeast cells when combined with vortexing

    • Enzymatic cell wall digestion: Using lyticase or zymolyase before gentle detergent lysis

    • Freeze-thaw cycles: Useful for preserving protein complexes

  • Protein denaturation conditions: For Western blot applications, samples should be denatured in Laemmli buffer at 95°C for 5 minutes, though some experiments may require non-denaturing conditions to preserve protein structure.

  • Protein concentration determination: Bradford or BCA assays should be used to normalize protein loading.

For microscopy applications, fixation with 4% paraformaldehyde followed by spheroplasting is generally recommended to maintain cellular architecture while allowing antibody penetration.

What controls should be included when using YLR163W-A antibody?

Proper experimental controls are essential for validating results with YLR163W-A antibody:

Control TypePurposeImplementation
Positive ControlConfirm antibody functionalityUse recombinant YLR163W-A protein or extract from cells known to express the protein
Negative ControlAssess non-specific bindingUse extract from YLR163W-A knockout strain
Loading ControlEnsure equal protein loadingDetect housekeeping proteins (e.g., GAPDH, actin)
Isotype ControlEvaluate background bindingUse non-specific IgG of same isotype and concentration
Peptide CompetitionVerify antibody specificityPre-incubate antibody with excess purified antigen before application
Secondary Antibody OnlyDetect non-specific bindingOmit primary antibody while including secondary antibody

These controls help distinguish genuine signals from artifacts and are particularly important for uncharacterized proteins like YLR163W-A where reference data may be limited .

How can I optimize the signal-to-noise ratio when using YLR163W-A antibody in challenging experiments?

Optimizing signal-to-noise ratio for YLR163W-A antibody applications involves multiple strategies:

  • Antibody titration: Perform systematic dilution series (typically 1:500 to 1:5000) to identify the optimal concentration that maximizes specific signal while minimizing background. Document signal intensity versus antibody concentration.

  • Blocking optimization:

    • Test multiple blocking agents: BSA (1-5%), non-fat dry milk (1-5%), casein, commercial blocking buffers

    • Evaluate different blocking durations: 30 minutes to overnight at 4°C

    • Consider adding 0.1-0.3% Triton X-100 or Tween-20 to reduce hydrophobic interactions

  • Extraction condition modification: For membrane or nuclear proteins, test different detergent combinations (CHAPS, digitonin, DDM) at varying concentrations.

  • Signal amplification systems:

    • Biotin-streptavidin systems

    • Tyramide signal amplification

    • Polymer-based detection systems

  • Instrumentation optimization:

    • For fluorescence applications, adjust exposure settings and utilize spectral unmixing

    • For chemiluminescence, optimize exposure time through multiple test exposures

Systematic recording of optimization experiments in a standardized format allows for reproducible protocols across different batches of samples .

What are potential cross-reactivity concerns with YLR163W-A antibody and how can they be addressed?

Cross-reactivity is a significant concern when working with antibodies against uncharacterized proteins:

  • Potential cross-reactivity sources:

    • Homologous proteins in yeast (paralogs)

    • Proteins with similar epitope structures

    • Highly abundant proteins that generate background binding

  • Cross-reactivity assessment methods:

    • Western blot analysis using YLR163W-A knockout strain

    • Mass spectrometry identification of immunoprecipitated proteins

    • Epitope mapping to identify potential cross-reactive regions

    • Preabsorption with recombinant protein to confirm specificity

  • Mitigation strategies:

    • Affinity purification of polyclonal antibodies against the specific antigen

    • Using monoclonal antibodies that recognize unique epitopes

    • Implementing stringent washing conditions in immunoassays

    • Pre-clearing lysates with non-specific IgG before immunoprecipitation

  • Validation across techniques:

    • Confirm results using orthogonal detection methods

    • Verify protein identity using mass spectrometry following immunoprecipitation

Cross-reactivity assessment is particularly important for antibodies against uncharacterized proteins where functional redundancy with other proteins might exist .

How can I integrate YLR163W-A antibody studies with other -omics approaches for comprehensive protein characterization?

Integration of YLR163W-A antibody studies with multi-omics approaches enables comprehensive protein characterization:

  • Proteomics integration:

    • Immunoprecipitation followed by mass spectrometry (IP-MS) to identify protein interaction partners

    • Correlation of antibody-based quantification with label-free or isotope-labeled quantitative proteomics

    • Validation of post-translational modifications identified in large-scale proteomic studies

  • Transcriptomics correlation:

    • Analysis of YLR163W-A protein expression in relation to mRNA levels across conditions

    • Investigation of potential post-transcriptional regulation mechanisms

    • Development of integrated expression profiles across environmental conditions

  • Functional genomics linkage:

    • Phenotypic analysis of YLR163W-A knockout or overexpression strains

    • Correlation with genetic interaction networks from large-scale screens

    • Systematic analysis across stress conditions to identify functional contexts

  • Data integration framework:

    • Utilization of gene ontology enrichment for interacting partners

    • Network analysis incorporating protein-protein interaction databases

    • Pathway mapping of YLR163W-A and associated proteins

  • Visualization tools:

    • Construction of integrated heatmaps showing protein expression, genetic interactions, and phenotypic data

    • Protein localization data integrated with interaction networks

Successful integration requires careful normalization of data from different platforms and consideration of the temporal dynamics of different molecular events .

What strategies can be applied to investigate contradictory results from YLR163W-A antibody experiments?

When faced with contradictory results in YLR163W-A antibody experiments, a systematic troubleshooting approach is necessary:

When presenting contradictory results, transparent reporting of all experimental conditions and analytical decisions is essential for scientific progress .

How can computational approaches enhance the interpretation of YLR163W-A antibody data?

Computational methods significantly enhance the interpretation of YLR163W-A antibody experimental data:

  • Image analysis for microscopy data:

    • Automated cell segmentation for quantification of subcellular localization

    • Colocalization analysis with known organelle markers

    • Single-cell quantification of protein expression heterogeneity

    • Time-lapse analysis for dynamic protein behavior

  • Quantitative analysis of immunoblots:

    • Densitometry standardization across experimental replicates

    • Implementation of local background subtraction methods

    • Statistical comparison across multiple conditions with appropriate tests

    • Normalization strategies for loading variations

  • Machine learning applications:

    • Pattern recognition in complex localization or expression datasets

    • Classification of phenotypes in knockout/knockdown experiments

    • Prediction of protein-protein interactions based on co-immunoprecipitation data

    • Integration of antibody-based data with public database information

  • Systems biology modeling:

    • Network inference incorporating YLR163W-A interactions

    • Pathway enrichment analysis for functional contextualization

    • Prediction of protein function based on interaction partners

    • Evolutionary analysis of protein conservation and divergence

  • Active learning approaches:

    • Iterative experimental design optimization based on machine learning models

    • Reduction of required experiments through intelligent sampling strategies

    • Improvement of out-of-distribution predictions for antibody-antigen interactions

    • Acceleration of binding prediction through optimized library-on-library approaches

The integration of computational approaches with antibody-based experimental data can reveal patterns and relationships not apparent through traditional analysis methods.

What are the optimal storage and handling conditions for YLR163W-A antibodies?

Proper storage and handling of YLR163W-A antibodies is crucial for maintaining activity and specificity:

  • Storage temperature guidelines:

    • Long-term storage: -80°C in small aliquots to avoid repeated freeze-thaw cycles

    • Medium-term storage: -20°C with glycerol or suitable cryoprotectant

    • Working stocks: 4°C for up to 2 weeks, depending on antibody stability

  • Buffer composition considerations:

    • PBS or TBS base buffer with pH 7.2-7.6

    • Addition of 0.02% sodium azide as preservative

    • For polyclonal antibodies: Addition of 50% glycerol for freeze protection

    • For certain applications: Addition of carrier proteins (BSA 1-5mg/ml)

  • Stability assessment protocol:

    • Periodic testing against standard controls

    • Monitoring antibody performance with consistent positive controls

    • Documentation of signal intensity across storage time

  • Handling precautions:

    • Minimize exposure to light for fluorophore-conjugated antibodies

    • Avoid repeated freeze-thaw cycles (maximum 5 recommended)

    • Use screw-cap microcentrifuge tubes to prevent evaporation

    • Centrifuge briefly before opening to collect solution

  • Reconstitution guidelines (for lyophilized antibodies):

    • Use sterile ddH₂O or recommended buffer

    • Allow complete solubilization at room temperature

    • Gentle mixing without vortexing to prevent denaturation

Implementing a quality control system with regular antibody validation checks ensures experimental reproducibility over time .

How can I develop a standardized protocol for reproducible YLR163W-A detection across experiments?

Developing standardized protocols for YLR163W-A detection requires careful attention to multiple experimental parameters:

  • Standardization components:

    • Detailed documentation of all reagents (catalog numbers, lot numbers)

    • Preparation of master mixes where possible to reduce pipetting variations

    • Inclusion of consistent positive and negative controls across experiments

    • Implementation of calibration standards for quantitative applications

  • Key parameters to control and document:

    ParameterStandardization ApproachDocumentation Requirements
    Antibody concentrationTitration to optimal signal:noiseLot number, dilution, diluent composition
    Incubation conditionsTime, temperature, agitation methodExact timing, equipment settings
    Washing stepsBuffer composition, volume, durationNumber of washes, volumes, timing
    Detection systemReagent preparation, exposure settingsLot numbers, equipment settings, gain values
    Sample preparationLysis method, protein quantificationCell density, buffer composition, storage conditions
  • Protocol validation process:

    • Inter-operator reproducibility testing

    • Cross-instrument validation where applicable

    • Statistical analysis of technical variability

    • Development of acceptance criteria based on control performance

  • Standard operating procedure (SOP) format:

    • Step-by-step instructions with timing

    • Decision trees for troubleshooting

    • Expected results with representative images

    • Quality control checkpoints throughout protocol

  • Data management standards:

    • Consistent file naming conventions

    • Raw data preservation guidelines

    • Analysis pipeline documentation

    • Results reporting templates

Implementing electronic laboratory notebooks with protocol versioning ensures experimental reproducibility and facilitates troubleshooting when variations occur .

What advanced techniques can be applied to study YLR163W-A protein interactions and dynamics?

Advanced techniques for studying YLR163W-A protein interactions and dynamics provide deeper insights beyond standard antibody applications:

  • Proximity-based interaction methods:

    • Proximity Ligation Assay (PLA) for detecting protein-protein interactions in situ

    • BioID or TurboID proximity labeling to identify neighboring proteins

    • FRET/BRET approaches using fluorescent protein fusions

    • Split complementation systems (BiFC, split luciferase) for interaction validation

  • Live-cell dynamics techniques:

    • Fluorescence Recovery After Photobleaching (FRAP) for mobility analysis

    • Single-molecule tracking with photoactivatable fluorescent proteins

    • Optogenetic control of protein localization and interactions

    • Fast time-resolution imaging with lattice light-sheet microscopy

  • Structural biology approaches:

    • Hydrogen-deuterium exchange mass spectrometry for interaction surfaces

    • Cross-linking mass spectrometry for interface mapping

    • Cryo-electron microscopy of complexes containing YLR163W-A

    • NMR analysis of purified protein domains and complexes

  • Quantitative interaction proteomics:

    • SILAC or TMT labeling for differential interactome analysis

    • Correlation profiling across biochemical fractionations

    • Thermal proteome profiling to assess complex stability

    • Absolute quantification of stoichiometry in complexes

  • Genome engineering approaches:

    • Endogenous tagging with split reporters for interaction mapping

    • Knock-in of fluorescent tags at the genomic locus

    • Anchor-Away or degron systems for rapid depletion studies

    • CRISPR interference/activation for expression modulation

These advanced techniques can be integrated with standard antibody-based approaches to create a comprehensive understanding of YLR163W-A function and interactions .

How should quantitative data from YLR163W-A antibody experiments be analyzed for statistical significance?

  • Experimental design considerations:

    • Power analysis to determine appropriate sample size

    • Randomization strategies to minimize batch effects

    • Blinding procedures for unbiased analysis

    • Inclusion of biological and technical replicates

  • Normalization strategies:

    • Internal reference genes/proteins for expression normalization

    • Total protein normalization (e.g., Ponceau S, Stain-Free technology)

    • Spike-in controls for absolute quantification

    • Batch correction methods for multi-experiment integration

  • Statistical test selection:

    Data TypeAppropriate TestsAssumptionsMultiple Testing Correction
    Two-group comparisont-test, Mann-WhitneyNormality (for t-test)Bonferroni, Benjamini-Hochberg
    Multi-group comparisonANOVA, Kruskal-WallisHomogeneity of varianceTukey HSD, Dunn's test
    Correlation analysisPearson, SpearmanLinearity, distributionN/A
    Time courseRepeated measures ANOVA, mixed modelsSphericity, missing data handlingPost-hoc specific comparisons
  • Visualization best practices:

    • Scatter plots showing individual data points alongside means/medians

    • Box plots displaying distribution characteristics

    • Visualization of effect sizes with confidence intervals

    • Consistent y-axis scaling to avoid visual distortion

  • Reporting guidelines:

    • Clear statement of statistical methods with justification

    • Exact p-values rather than significance thresholds

    • Confidence intervals for effect size estimates

    • Transparent reporting of outlier handling and exclusion criteria

Implementing a standardized data analysis pipeline with documentation of all statistical decisions enhances reproducibility and facilitates meta-analysis across studies .

What are the considerations for interpreting YLR163W-A localization studies using immunofluorescence?

Interpreting YLR163W-A localization studies requires careful consideration of multiple factors:

  • Fixation method effects:

    • Paraformaldehyde: Good structure preservation but may mask some epitopes

    • Methanol: Better for certain epitopes but disrupts membrane structures

    • Glutaraldehyde: Strong fixation but higher autofluorescence

    • Comparison of results across fixation methods for validation

  • Resolution considerations:

    • Diffraction-limited confocal: ~200-250 nm lateral resolution

    • Super-resolution techniques: Improved resolution to 20-100 nm

    • Electron microscopy correlation: Nanometer-scale localization with immunogold

    • Impact of resolution on interpretation of colocalization data

  • Colocalization analysis:

    • Quantitative colocalization metrics (Pearson's, Manders' coefficients)

    • Point spread function considerations in optical microscopy

    • 3D reconstruction for volumetric colocalization assessment

    • Statistical significance testing for colocalization coefficients

  • Dynamics interpretation:

    • Cell cycle phase considerations

    • Response to environmental conditions or stress

    • Temporal dynamics during developmental processes

    • Protein mobility assessment through photobleaching recovery

  • Common artifacts and controls:

    • Fixation-induced protein redistribution

    • Antibody accessibility limitations in dense structures

    • Background autofluorescence from metabolites

    • Use of tagged proteins as complementary approach

  • Quantification approaches:

    • Intensity-based measurements across subcellular regions

    • Object-based analysis of punctate structures

    • Population heterogeneity assessment

    • Correlation with functional assays for biological validation

Integration of localization data with functional studies provides context for interpreting the significance of YLR163W-A subcellular distribution .

How can I integrate findings from multiple techniques to build a comprehensive model of YLR163W-A function?

Building a comprehensive model of YLR163W-A function requires systematic integration of data from multiple experimental approaches:

  • Multi-technique triangulation strategy:

    • Biochemical approaches: Purification, enzymatic assays, binding studies

    • Cell biology techniques: Localization, trafficking, stress response

    • Genetic methods: Knockout phenotypes, synthetic interactions

    • Structural biology: Domain architecture, interaction surfaces

    • Systems approaches: Network context, pathway involvement

  • Hierarchical data integration framework:

    • Primary structure and modifications (sequence, PTMs)

    • Secondary/tertiary structure (domains, folding)

    • Quaternary structure (complexes, oligomerization)

    • Subcellular localization and trafficking

    • Physiological function and regulation

  • Computational modeling approaches:

    • Homology-based function prediction

    • Molecular dynamics simulations

    • Network-based function inference

    • Evolutionary analysis for functional constraints

  • Functional annotation synthesis:

    • Gene Ontology term assignment with evidence codes

    • Pathway mapping with confidence scoring

    • Phenotypic signature analysis across conditions

    • Disease relevance in higher eukaryotic homologs

  • Visualization and communication tools:

    • Integrated data visualization dashboards

    • Molecular graphics of structural features

    • Dynamic models of temporal regulation

    • Accessible summaries for different audience expertise levels

  • Knowledge gaps identification:

    • Systematic documentation of contradictory findings

    • Structured approach to hypothesis generation

    • Prioritization of experiments to resolve uncertainties

    • Collaboration strategies for technique specialization

This integrated approach transforms isolated experimental findings into a coherent functional model with clearly indicated confidence levels and remaining uncertainties .

What emerging technologies might enhance YLR163W-A antibody-based research in the next five years?

Several emerging technologies promise to transform antibody-based research for proteins like YLR163W-A:

  • Next-generation antibody technologies:

    • Nanobodies and single-domain antibodies for improved penetration

    • DNA-barcoded antibodies for highly multiplexed detection

    • Recombinant antibody engineering for enhanced specificity

    • Photoswitchable antibodies for super-resolution applications

  • Single-cell proteomics integration:

    • Mass cytometry (CyTOF) for single-cell protein profiling

    • Microfluidic platforms for antibody-based single-cell analysis

    • Spatial proteomics with multiplexed antibody imaging

    • Integration with single-cell transcriptomics for multi-omic profiling

  • In situ structural analysis:

    • Proximity labeling with residue-level resolution

    • Correlative light and electron microscopy with specific labeling

    • Cryo-electron tomography of cellular structures

    • 4D visualization of protein dynamics in living cells

  • AI and machine learning applications:

    • Deep learning for image analysis and pattern recognition

    • Predictive modeling of protein interactions and functions

    • Automated experimental design optimization

    • Natural language processing for literature mining and hypothesis generation

  • Microproteomic approaches:

    • Ultrasensitive detection from limited samples

    • Single-molecule antibody-based detection methods

    • Nano-immunoprecipitation from subcellular structures

    • Targeted proteomics with antibody-guided mass spectrometry

These technologies will enable more sensitive, specific, and comprehensive analysis of uncharacterized proteins like YLR163W-A, potentially revealing functions that have remained elusive with current methods .

How should researchers design follow-up studies to characterize the function of YLR163W-A?

Strategic design of follow-up studies for YLR163W-A functional characterization:

This strategic approach to follow-up studies maximizes the probability of identifying the biological function of this uncharacterized protein while minimizing experimental bias and artifacts .

What are the major challenges and opportunities in YLR163W-A antibody-based research?

YLR163W-A antibody research presents unique challenges and opportunities that shape the field's trajectory:

  • Current challenges:

    • Limited functional characterization hampers hypothesis development

    • Potential cross-reactivity with related proteins requires rigorous validation

    • Low expression levels may necessitate sensitive detection methods

    • Reproducibility across different antibody lots and laboratories

    • Integration of data from various techniques into coherent models

  • Emerging opportunities:

    • Application of systems biology approaches for functional prediction

    • Development of engineered strains for controlled expression

    • Integration with structural biology for mechanistic insights

    • Computational modeling to guide experimental design

    • Comparative studies across model organisms for evolutionary insights

  • Methodological advancements:

    • Increased antibody specificity through recombinant approaches

    • Enhanced sensitivity through signal amplification technologies

    • Multiplexed detection for contextual protein analysis

    • Quantitative imaging with improved spatial and temporal resolution

    • Integration with CRISPR-based genetic manipulation

  • Collaborative frameworks:

    • Cross-disciplinary approaches combining expertise

    • Data sharing initiatives for maximal knowledge extraction

    • Standardization efforts for improved reproducibility

    • Open science practices to accelerate discovery

Researchers working with YLR163W-A and similar uncharacterized proteins face the dual challenge of developing reliable experimental methods while simultaneously generating hypotheses about protein function. The field continues to evolve toward integrated approaches that leverage multiple technologies and computational methods to build comprehensive functional models .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.